Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(100.0%)
3Total
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04796428Phase 4Unknown

GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial

Role: collaborator

NCT00700856Phase 4Unknown

Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial

Role: lead

NCT00715481Completed

Renal Insufficiency And Cardiovascular Events

Role: collaborator

NCT01240070Phase 4Unknown

Multifactorial Intervention in Type 2 Diabetes - Italy

Role: collaborator

NCT00879801Completed

Genetic Physiopathology and Evolution of Type 2 Diabetes

Role: collaborator

All 5 trials loaded